Back to search
Streptococcus Pneumonia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Streptococcus Pneumonia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Streptococcus Pneumonia trials you may qualify forThis phase II trial tests whether the pneumococcal pneumonia vaccine series (PCV20 and PPSV23) works to mount an effective immune response in patients with chro…
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
This is an epidemiology study for the prevalence and serotypes of pneumococcus pneumoniae in hospitalized patients with community acquired pneumonia (CAP). The…
Background: China's healthcare system for children faces significant challenges, particularly due to the limited pediatric service capacity of primary healthcar…
Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infe…
Severe community-acquired pneumonia (CAP) and community-acquired aspiration pneumonia (CAAP) are common reasons for adult emergency department visits and subseq…
The main objective of the study is to evaluate the persistence of the immunoglobulin G (IgG) antibody responses, specific to Alpha-like protein CN (AlpCN), Ribo…